Skip to main content
. 2017 Jun 27;8(37):62414–62424. doi: 10.18632/oncotarget.18620

Figure 3. Pooled risk estimates of HT for PTC risk (HT versus non-HT).

Figure 3

HT, Hashimoto’s thyroiditis; PTC, papillary thyroid carcinoma.